Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Vera Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +2 vs. Q1 2022
- Shares held
- 20.4M
- +721.9K (+3.7%) vs. Q1 2022
- Total value
- $277.6M
- −$191.3M (−40.8%) vs. Q1 2022
- New holders
- 6
- 20 more added
- Sold out
- 4
- 11 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of Wyoming | 28 | $0 | 0.00% | +28 | New |
| Wells Fargo & Company | 343 | $5.00K | 0.00% | −2,612−88.4% | Reduced |
| UBS Group AG | 395 | $5.00K | 0.00% | −1,614−80.3% | Reduced |
| Royal Bank of Canada | 578 | $8.00K | 0.00% | −763−56.9% | Reduced |
| Barclays PLC | 696 | $9.00K | 0.00% | −1,526−68.7% | Reduced |
| Ameritas Investment Partners, Inc. | 1,061 | $14.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,041 | $14.2K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,430 | $19.0K | 0.00% | +1,203+530.0% | Added |
| STRS Ohio | 1,600 | $21.0K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 2,157 | $29.0K | 0.00% | +719+50.0% | Added |
| Morgan Stanley | 3,465 | $47.0K | 0.00% | −15,053−81.3% | Reduced |
| Legal & General Group Plc | 4,898 | $67.0K | 0.00% | +3,591+274.8% | Added |
| American International Group, Inc. | 6,488 | $88.0K | 0.00% | −306−4.5% | Reduced |
| Deutsche Bank AG | 8,573 | $116.0K | 0.00% | +469+5.8% | Added |
| MetLife Investment Management | 8,881 | $120.9K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 9,604 | $131.0K | 0.00% | +9,604 | New |
| Cambridge Trust Co | 9,887 | $135.0K | 0.01% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 10,982 | $149.0K | 0.00% | −10.0% | Reduced |
| Citigroup Inc | 11,230 | $153.0K | 0.00% | +335+3.1% | Added |
| Dynamic Technology Lab Private Ltd | 11,939 | $162.0K | 0.02% | +11,939 | New |
| Ensign Peak Advisors, Inc | 13,277 | $181.0K | 0.00% | 00.0% | Unchanged |
| Carnegie Mellon University | 16,060 | $219.0K | 0.11% | 00.0% | Unchanged |
| Alps Advisors Inc | 16,060 | $219.0K | 0.00% | +16,060 | New |
| Rhumbline Advisers | 16,272 | $221.0K | 0.00% | +5,887+56.7% | Added |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $243.0K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 18,554 | $253.0K | 0.00% | +12,704+217.2% | Added |
| Bank of America Corp | 21,454 | $292.0K | 0.00% | +5,850+37.5% | Added |
| Swiss National Bank | 34,700 | $472.0K | 0.00% | +34,700 | New |
| Charles Schwab Investment Management Inc | 34,691 | $473.0K | 0.00% | −52−0.1% | Reduced |
| Nuveen Asset Management, LLC | 74,322 | $1.01M | 0.00% | +20,699+38.6% | Added |
| Bank of New York Mellon Corp | 75,084 | $1.02M | 0.00% | +26,248+53.7% | Added |
| JPMorgan Chase & Co | 98,936 | $1.35M | 0.00% | −50,665−33.9% | Reduced |
| Bank of Montreal | 96,849 | $1.41M | 0.00% | +96,849 | New |
| Northern Trust Corp | 112,470 | $1.53M | 0.00% | +3,063+2.8% | Added |
| Geode Capital Management, LLC | 204,588 | $2.78M | 0.00% | +2,041+1.0% | Added |
| State Street Corp | 222,255 | $3.02M | 0.00% | +53,498+31.7% | Added |
| Millennium Management LLC | 276,243 | $3.76M | 0.00% | +142,743+106.9% | Added |
| Polar Asset Management Partners Inc. | 294,300 | $4.00M | 0.05% | +234,300+390.5% | Added |
| Alphabet Inc. | 301,580 | $4.11M | 0.22% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 333,333 | $4.54M | 0.03% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 575,000 | $7.83M | 2.09% | 00.0% | Unchanged |
| Vivo Capital, LLC | 666,666 | $9.07M | 0.91% | 00.0% | Unchanged |
| Vanguard Group Inc | 676,937 | $9.21M | 0.00% | +58,934+9.5% | Added |
| BlackRock Inc. | 717,034 | $9.76M | 0.00% | +37,359+5.5% | Added |
| Kynam Capital Management, LP | 1,522,712 | $20.7M | 5.35% | +1,020,384+203.1% | Added |
| Ra Capital Management, L.P. | 1,578,820 | $21.5M | 0.57% | −387,264−19.7% | Reduced |
| Citadel Advisors LLC | 2,122,851 | $28.9M | 0.04% | +33,331+1.6% | Added |
| Abingworth LLP | 2,960,231 | $40.3M | 12.90% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,181,442 | $43.3M | 3.85% | 00.0% | Unchanged |
| FMR LLC | 4,015,351 | $54.6M | 0.01% | +3,321+0.1% | Added |
| International Biotechnology Trust PLC | 3,825 | – | – | −186,924−98.0% | Reduced |
| Logos Global Management LP | 0 | $0 | 0.00% | −385,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −64,240−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −16,961−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |